QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in Cash. Represents a 139.7% premium to most recent Nasdaq closing price. Transaction expected to close ...
In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their ...
Many people like to snack on peanut butter with apple slices for the vitamin E, but you have to be careful of other ...
Teva Pharmaceuticals has a new game plan for raising awareness of tardive dyskinesia (TD). | Teva Pharmaceuticals has a new ...
Involuntary movements caused by tardive dyskinesia (TD), a movement disorder induced by dopamine-receptor antagonists like ...
This football season, Teva is increasing education around tardive dyskinesia (TD) by launching 'The Other TD' campaignTD is a chronic movement disorder impacting one in four people who take certain pr ...
This football season, Teva is increasing education around tardive dyskinesia (TD) by launching ‘The Other TD’ campaignTD is a ...
TipRanks on MSN
Teva launches ‘The Other TD’ disease education campaign
Pharmaceuticals announced the launch of ‘The Other TD,’ a disease education campaign leveraging the broad recognition of football ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback